Expanding physiology beyond the wire: will 2026 be the defining year? [0.03%]
超越导线的生理学：2026年会成为决定性的一年吗？
Gianluca Campo,Simone Biscaglia
Gianluca Campo
Derivation and external validation of a deep learning model to predict changes in coronary plaque burden [0.03%]
冠状动脉斑块负担变化的深度学习预测模型的建立和外部验证
Hector M García-García,Carlos A Bulant,Gustavo A Boroni et al.
Hector M García-García et al.
Background: Predicting the progression/regression of coronary plaque burden is challenging. Aims: We aimed to develop a deep learning m...
Salvatore Brugaletta,Luis Ortega-Paz,Josep Gómez-Lara et al.
Salvatore Brugaletta et al.
Primary percutaneous coronary intervention is currently the standard of care for the treatment of acute ST-segment elevation myocardial infarction (STEMI). While it can restore flow in the infarcted artery in the majority of cases, some pat...
Natural history of coronary plaque redistribution after drug-coated balloon angioplasty [0.03%]
药物涂层球囊成形术后冠状动脉斑块分布的自然史变化研究
Magdalena M Dobrolińska,Wojciech J Skorupski,Mariusz Kruk et al.
Magdalena M Dobrolińska et al.
Drug-coated balloons for the treatment of coronary artery bypass graft failure [0.03%]
药物涂层球囊在冠脉旁路移植失败中的应用
Alexander Marschall,Jorge F Chavez-Solsol,Nieves Gonzalo et al.
Alexander Marschall et al.
Quantitative flow ratio versus fractional flow reserve: 2-year follow-up of the FAVOR III Europe trial [0.03%]
定量血流分数与压力导丝测量的鲁分血流储备分数：FAVOR III Europe研究两年随访结果
Birgitte K Andersen,Niels R Holm,Martin Sejr-Hansen et al.
Birgitte K Andersen et al.
Background: Quantitative flow ratio (QFR) is an angiography-based method for estimating fractional flow reserve (FFR). The FAVOR III Europe trial showed that QFR guidance did not meet non-inferiority to FFR guidance, as m...
Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons [0.03%]
药物涂层球囊治疗冠状动脉原发性病变的血管内影像指导
Nicolas Amabile,Nieves Gonzalo,Antoinette Neylon et al.
Nicolas Amabile et al.
Stable coronary patients with atrial fibrillation: when the kidneys tip the balance [0.03%]
冠状动脉疾病稳定型房颤患者：当肾脏功能影响预后时
Martine Gilard,Romain Didier
Martine Gilard
Impact of device implantation depth on blood flow dynamics after left atrial appendage closure [0.03%]
左心耳封堵术中装置植入深度对血流动力学影响的研究
Pedro Cepas-Guillén,Carlos Albors,Jordi Mill et al.
Pedro Cepas-Guillén et al.
Background: Device-related thrombus (DRT) remains a concern after left atrial appendage closure (LAAC), particularly when the device is deeply implanted. However, the mechanistic links between implantation depth, flow dyn...
No antithrombotic therapy versus single antiplatelet therapy after percutaneous left atrial appendage closure in non-valvular atrial fibrillation: rationale and design of the multicentre, randomised, non-inferiority NAPT-LAAC trial [0.03%]
非瓣膜性房颤患者左心耳封堵术后单用抗血小板药与不用抗栓药的非劣效性研究：NAPT-LAAC多中心随机对照试验的设计和原理
Toshiaki Otsuka,Masanori Yamamoto,Masahiko Asami et al.
Toshiaki Otsuka et al.
The current standard regimen for antithrombotic therapy after percutaneous left atrial appendage closure (LAAC) in patients with non-valvular atrial fibrillation (NVAF) recommends long-term use of antiplatelet agents. However, this recommen...